Loading…

CELERIS - Owned by Celeris Therapeutics GmbH - (Class 042) | Sealvo

Home Search: CELERISCELERIS #79322625

Updated Sep 28, 2026·16 searches this week

View on USPTO TSDR Find similar marks

CEL

USPTO Trademark Record

ABANDONED

CELERIS

SN 79322625·Reg 0·Filed Apr 29, 2021

Owner Celeris Therapeutics GmbH

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CELERIS (Serial No. 79322625), Registration No. 0, is a abandoned US trademark filed on Apr 29, 2021 by Celeris Therapeutics GmbH. This trademark covers Class 042 (Scientific, technology & SaaS services).

Conflict Analysis

Full conflict analysis for CELERIS (SN 79322625) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

CELERIS (Reg. #0) is an abandoned US trademark that was filed in 2021 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 11 opposition proceedings during prosecution.

FILED

Apr 29, 2021

SERIAL

79322625

REG#

0

REGISTERED

Dec 31, 1969

Filing Information

StatusABANDONED

Filing DateApr 29, 2021

Serial Number79322625

Registration No.0

Registration DateDec 31, 1969

Status DateJun 16, 2023

Published for OppositionOct 04, 2022

Full Goods & Services

CLASSES

1

OFFICE

USPTO

COUNTRY

US

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

37 events

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Jul 05, 2023

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Jul 04, 2023

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

DEATH OF INTERNATIONAL REGISTRATION

Jul 04, 2023

DEATH OF INTERNATIONAL REGISTRATION

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Jul 03, 2023

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

DEATH OF INTERNATIONAL REGISTRATION

Jul 03, 2023

DEATH OF INTERNATIONAL REGISTRATION

DEATH OF INTERNATIONAL REGISTRATION

Jul 02, 2023

DEATH OF INTERNATIONAL REGISTRATION

OPPOSITION DISMISSED NO. 999999

Jun 27, 2023

OPPOSITION DISMISSED NO. 999999

OPPOSITION TERMINATED NO. 999999

Jun 27, 2023

OPPOSITION TERMINATED NO. 999999

ABANDONMENT - AFTER INTER PARTES DECISION

Jun 27, 2023

ABANDONMENT - AFTER INTER PARTES DECISION

ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION

Jun 27, 2023

ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Apr 04, 2023

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Mar 15, 2023

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Mar 15, 2023

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

REFUSAL PROCESSED BY IB

Feb 07, 2023

REFUSAL PROCESSED BY IB

OPPOSITION INSTITUTED NO. 999999

Jan 20, 2023

OPPOSITION INSTITUTED NO. 999999

OPPOSITION NOTICE (IB REFUSAL) CREATED

Jan 18, 2023

OPPOSITION NOTICE (IB REFUSAL) CREATED

OPPOSITION NOTICE (IB REFUSAL) SENT TO IB

Jan 18, 2023

OPPOSITION NOTICE (IB REFUSAL) SENT TO IB

EXTENSION OF TIME TO OPPOSE RECEIVED

Oct 31, 2022

EXTENSION OF TIME TO OPPOSE RECEIVED

PUBLISHED FOR OPPOSITION

Oct 04, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 04, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Oct 03, 2022

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 14, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Sep 14, 2022

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Sep 14, 2022

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 29, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 02, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 02, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 02, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Feb 20, 2022

REFUSAL PROCESSED BY IB

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Feb 03, 2022

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

REFUSAL PROCESSED BY MPU

Feb 02, 2022

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jan 12, 2022

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Jan 11, 2022

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Dec 29, 2021

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Oct 26, 2021

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 20, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Oct 14, 2021

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Celeris Therapeutics GmbH

Additional USPTO filings from the same owner.

HADES

79322626

Celeris Therapeutics GmbH

XANTHOS

79322627

Celeris Therapeutics GmbH

HEPHAISTOS

79322628

Celeris Therapeutics GmbH

CELERIS THERAPEUTICS

79377993

Celeris Therapeutics GmbH

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

CELERIS

77576355

Celeris Systems, Inc.

CELERIS

75589069

CELERIS CORPORATION

CELERIS

74717664

DOW CHEMICAL COMPANY, THE

CELERIS THERAPEUTICS

79377993

Celeris Therapeutics GmbH